Exact Mass: 534.1585

Exact Mass Matches: 534.1585

Found 42 metabolites which its exact mass value is equals to given mass value 534.1585, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CERCOSPORIN

Cercosporin from Cercospora hayii

C29H26O10 (534.1526)


An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora. CONFIDENCE isolated standard

   

Aprepitant

3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one

C23H21F7N4O3 (534.1502)


Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV). A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.

   

ent-Aprepitant

3-[(2-{1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one

C23H21F7N4O3 (534.1502)


   

Amphicercosporin

Amphicercosporin

C29H26O10 (534.1526)


   

Neocercosporin

Neocercosporin

C29H26O10 (534.1526)


   

Rocaglamide derivative 9

Rocaglamide derivative 9

C29H26O10 (534.1526)


   

1-O-[(E)-3,4-dihydroxy-5-methoxycinnamoyl]gentiobiose

1-O-[(E)-3,4-dihydroxy-5-methoxycinnamoyl]gentiobiose

C22H30O15 (534.1585)


   

Hexa-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose|Hexa-Ac-beta-Pyranose-Xylobiose

Hexa-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose|Hexa-Ac-beta-Pyranose-Xylobiose

C22H30O15 (534.1585)


   

2, 4, 5, 7, 8, 9-Hexa-Ac, Me ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI

2, 4, 5, 7, 8, 9-Hexa-Ac, Me ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI

C22H30O15 (534.1585)


   

Aprepitant

3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one

C23H21F7N4O3 (534.1502)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.

   

Cys Cys Phe Tyr

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H30N4O6S2 (534.1607)


   

Cys Cys Tyr Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Cys Phe Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H30N4O6S2 (534.1607)


   

Cys Phe Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Cys Tyr Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Cys Tyr Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Phe Cys Cys Tyr

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H30N4O6S2 (534.1607)


   

Phe Cys Tyr Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Phe Tyr Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Tyr Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Tyr Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

Tyr Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C24H30N4O6S2 (534.1607)


   

(1R,2R,3R)-Aprepitant

(1R,2R,3R)-Aprepitant

C23H21F7N4O3 (534.1502)


   
   
   

(1S,2S,3S)-Aprepitant

(1S,2S,3S)-Aprepitant

C23H21F7N4O3 (534.1502)


   

(H-Cys-Phe-OH)2 (Disulfide bond)

(H-Cys-Phe-OH)2 (Disulfide bond)

C24H30N4O6S2 (534.1607)


   

5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one

5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one

C23H21F7N4O3 (534.1502)


   

Cercosporin, pure

Cercosporin, pure

C29H26O10 (534.1526)


   

sodium[alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll]

sodium[alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll]

C20H31NaO15 (534.1561)


   

Cercosporin from Cercospora hayii

Cercosporin from Cercospora hayii

C29H26O10 (534.1526)


   

UPGL00004

UPGL00004

C25H26N8O2S2 (534.162)


UPGL00004 is a potent allosteric glutaminase C (GAC) inhibitor (IC50=29 nM; Kd=27 nM). UPGL00004 strongly inhibits the proliferation of highly aggressive triple-negative breast cancer cell lines[1].

   

9,17-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione

9,17-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione

C29H26O10 (534.1526)


   

7,19-dihydroxy-5,21-bis[(2s)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

7,19-dihydroxy-5,21-bis[(2s)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

C29H26O10 (534.1526)


   

methyl (2s,3r,4r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate

methyl (2s,3r,4r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate

C29H26O10 (534.1526)


   

3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate

3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate

C22H30O15 (534.1585)


   

methyl 6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate

methyl 6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate

C29H26O10 (534.1526)


   

7,19-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

7,19-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

C29H26O10 (534.1526)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2e)-3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2e)-3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate

C22H30O15 (534.1585)


   

7,19-dihydroxy-5,21-bis[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

7,19-dihydroxy-5,21-bis[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

C29H26O10 (534.1526)


   

7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione

C29H26O10 (534.1526)


   

9,17-dihydroxy-5,21-bis[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione

9,17-dihydroxy-5,21-bis[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione

C29H26O10 (534.1526)